1
|
Ali SF, Cloe A, Siaghani PJ, Himchak E, Cantu D, Gaal K, Kim YS, Afkhami M, Pillai R, Chan W, Quirk E, Weisenburger DD, Aoun P, Song JY. Bone Marrow Collection: Comparison of Unassisted vs Assisted Bedside Collections by a Laboratory Technologist. Am J Clin Pathol 2022; 157:573-577. [PMID: 34788366 DOI: 10.1093/ajcp/aqab165] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2021] [Accepted: 08/24/2021] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVES Bone marrow collections are often difficult, and creating quality smears and touch preparations at the bedside can prove challenging. The objective of this study is to compare the quality of bone marrow specimens between unassisted and assisted bone marrow collections by a bone marrow technologist. METHODS Data for this study were collected from 422 hematopathology reports over 14 months. We recorded the bone marrow quality of the different parts (aspirate smears, touch imprints, core biopsy, and clot/particle sections) as adequate, suboptimal, or inadequate. Student t test statistical analysis was performed between the corresponding parts in the two groups. RESULTS Our results demonstrate that the quality of assisted bone marrow specimens is significantly better compared with unassisted specimens, particularly for the aspirate smears (P < .0001) and touch imprints (P < .0001). Notably, the quality of aspirate smears was improved, which is important for cytologic evaluation. CONCLUSIONS We conclude that assistance by a bone marrow technologist resulted in a significant improvement in the quality of bone marrow collection.
Collapse
Affiliation(s)
- Saba F Ali
- Department of Pathology, Roswell Park, Buffalo, NY, USA
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA
| | - Adam Cloe
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA
- Quest Diagnostics, Woodland Hills, CA, USA
| | - Parwiz J Siaghani
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA
- Long Beach Memorial Medical Center, Long Beach, CA, USA
| | - Evan Himchak
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA
- Department of Pathology, Texas Health Presbyterian Hospital, Dallas, TX, USA
| | - David Cantu
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA
- Department of Pathology, Creighton University School of Medicine, Omaha, NE, USA
| | - Karl Gaal
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA
| | - Young S Kim
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA
| | - Michelle Afkhami
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA
| | - Raju Pillai
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA
| | - Wanda Chan
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA
| | - Elizabeth Quirk
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA
| | | | - Patricia Aoun
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA
| | - Joo Y Song
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA
| |
Collapse
|
2
|
Pritzker KPH, Nieminen HJ. Needle Biopsy Adequacy in the Era of Precision Medicine and Value-Based Health Care. Arch Pathol Lab Med 2019; 143:1399-1415. [PMID: 31100015 DOI: 10.5858/arpa.2018-0463-ra] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
CONTEXT.— Needle biopsy of diseased tissue is an essential diagnostic tool that is becoming even more important as precision medicine develops. However, the capability of this modality to efficiently provide samples adequate for diagnostic and prognostic analysis remains quite limited relative to current diagnostic needs. For physicians and patients, inadequate biopsy frequently leads to diagnostic delay, procedure duplication, or insufficient information about tumor biology leading to delay in treatment; for health systems, this results in substantial incremental costs and inefficient use of scarce specialized diagnostic resources. OBJECTIVE.— To review current needle biopsy technology, devices, and practice with a perspective to identify current limitations and opportunities for improvement in the context of advancing precision medicine. DATA SOURCES.— PubMed searches of fine-needle aspiration and core needle biopsy devices and similar technologies were made generally, by tissue site, and by adequacy as well as by health economics of these technologies. CONCLUSIONS.— Needle biopsy adequacy can be improved by recognizing the importance of this diagnostic tool by promoting common criteria for needle biopsy adequacy; by optimizing needle biopsy procedural technique, technologies, clinical practice, professional education, and quality assurance; and by bundling biopsy procedure costs with downstream diagnostic modalities to provide better accountability and incentives to improve the diagnostic process.
Collapse
Affiliation(s)
- Kenneth P H Pritzker
- From the Departments of Laboratory Medicine and Pathobiology, and Surgery, University of Toronto, Toronto, Ontario, Canada (Dr Pritzker); and the Department of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland (Dr Nieminen)
| | - Heikki J Nieminen
- From the Departments of Laboratory Medicine and Pathobiology, and Surgery, University of Toronto, Toronto, Ontario, Canada (Dr Pritzker); and the Department of Neuroscience and Biomedical Engineering, Aalto University School of Science, Espoo, Finland (Dr Nieminen)
| |
Collapse
|
3
|
Reed LJ, Attarian S, Olson TR, Singh S, Shestopalov A, Friedman EW. Feasibility and safety of targeting the anterior superior iliac spine to perform a bone marrow procedure: a prospective, clinical study. J Clin Pathol 2018; 71:1116-1119. [PMID: 30352912 DOI: 10.1136/jclinpath-2018-205309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2018] [Revised: 08/13/2018] [Accepted: 08/21/2018] [Indexed: 11/04/2022]
Abstract
AIMS The bone marrow procedure (BMP) has been performed worldwide for years. Nonetheless, no generally accepted standards or guidelines for the performance of the BMP exist. Recent studies suggested that the lateral angulation technique (LAT), targeting the anterior superior iliac spine (ASIS) after penetration of the posterior superior iliac spine, yields longer biopsy cores and is safer for patients. We assessed the feasibility and safety of targeting the ASIS in the prone and lateral decubitus positions. METHODS We first observed the BMP needle tracks on cadavers. Our cadaver study revealed that the LAT is feasible and safe but requires different operator techniques. Next, we studied 25 adult haematology patients undergoing elective BMP via the LAT approach. Patients returned 5 days after the BMP for a haemoglobin assessment, pain questionnaire and low-dose non-contract CT. RESULTS 8% of patients reported persistent pain. No fall in haemoglobin and no pelvic haematomas or neurovascular injuries were detected. 88% of BMPs were successfully accomplished by targeting the ASIS. 12% required a back-up traditional angulation technique (TAT), directing the needle straight in, perpendicular to the coronal plane of the back. All three demonstrated inadvertent, but asymptomatic, penetration of the sacrum. Biopsy lengths were compared with a historical TAT control demonstrating that specimens obtained by LAT are significantly longer. Imaging studies showed that a seven-degree change in needle direction can convert a TAT to a LAT. CONCLUSION The LAT approach is feasible, safe and more productive than the TAT, and may be the preferred standard for training haematologists. TRIAL REGISTRATION NUMBER NCT02524613.
Collapse
Affiliation(s)
- Loius J Reed
- Department of Oncology, Jacobi Medical Center, Bronx, New York, USA
| | - Shirin Attarian
- Division of Oncology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA .,Northwell Health, Monter Cancer Center, Lake Success, New York, USA
| | - Todd R Olson
- Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, New York, USA
| | - Shashi Singh
- Department of Radiology, Jacobi Medical Center, Bronx, New York, USA
| | | | - Ellen W Friedman
- Division of Hematology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA
| |
Collapse
|
4
|
Attarian S, Reed L, Singh S, Shestopalov A, Singh AP, Budhathoki A, Abi-Aad S, Shah UA, Kim S, Bachiashvili K, Elrafei T, Li W, Yee C, Friedman EW. Visualization of the bone marrow biopsy needle track. Am J Hematol 2018; 93:E60-E61. [PMID: 29168229 DOI: 10.1002/ajh.24985] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2017] [Accepted: 11/20/2017] [Indexed: 11/12/2022]
Affiliation(s)
- Shirin Attarian
- Department of Hematology/Oncology; Montefiore Medical Center; Bronx NY 10467
| | - Louis Reed
- Department of Hematology/Oncology; Montefiore Medical Center; Bronx NY 10467
| | - Shashi Singh
- Department of Hematology/Oncology; Montefiore Medical Center; Bronx NY 10467
| | | | - Aditi P Singh
- Department of Hematology/Oncology; Montefiore Medical Center; Bronx NY 10467
| | - Anjali Budhathoki
- Department of Hematology/Oncology; Montefiore Medical Center; Bronx NY 10467
| | - Simon Abi-Aad
- Department of Hematology/Oncology; Montefiore Medical Center; Bronx NY 10467
| | - Urvi A Shah
- Department of Hematology/Oncology; Montefiore Medical Center; Bronx NY 10467
| | - Salem Kim
- Department of Hematology/Oncology; Montefiore Medical Center; Bronx NY 10467
| | - Kimo Bachiashvili
- Department of Hematology/Oncology; Montefiore Medical Center; Bronx NY 10467
| | - Tarek Elrafei
- Department of Hematology/Oncology; Montefiore Medical Center; Bronx NY 10467
| | - Weijuan Li
- Department of Hematology/Oncology; Montefiore Medical Center; Bronx NY 10467
| | - Conway Yee
- Department of Hematology/Oncology; Montefiore Medical Center; Bronx NY 10467
| | - Ellen W Friedman
- Department of Hematology/Oncology; Montefiore Medical Center; Bronx NY 10467
| |
Collapse
|